Anticipate generic drug launch
Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Method of lessening the risk of non-vertebral bone fractures|
|Abstract:||Alendronate, a bisphosphonate, when administered daily over a substantial period of time, can reduce the rate of non-vertebral fractures, in post-menopausal women.|
|Inventor(s):||Santora, II; Arthur C. (Watchung, NJ), Karpf; David B. (North Brunswick, NJ), Polvino; William J. (Bridgewater, NJ), Shapiro; Deborah Ruth (Edison, NJ), Thompson; Desmond E. (Martinsville, NJ), Yates; Ashley John (Westfield, NJ)|
|Assignee:||Merck & Co., Inc. (Rahway, NJ)|
Patent Claim Types:|
see list of patent claims
Field: Not categorized
Back Citations: 9th percentile
Forward Citations: 5th percentile
|Patent Number||Expiration Date|
|5,804,570||September 09, 2002|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Argentina||002707||<disabled in preview>|
|Australia||4922796||<disabled in preview>|
|Australia||4979996||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.